Chambon M, Koenig A
Transpl Int. 2024; 37:13318.
PMID: 39479216
PMC: 11521863.
DOI: 10.3389/ti.2024.13318.
Loh L, Saunders P, Faoro C, Font-Porterias N, Nemat-Gorgani N, Harrison G
Cell. 2024; 187(24):7008-7024.e19.
PMID: 39476840
PMC: 11606752.
DOI: 10.1016/j.cell.2024.10.005.
Ford M, Hari A, Zhou Q, Numanagic I, Sahinalp S
Bioinformatics. 2024; 40(11).
PMID: 39432666
PMC: 11549020.
DOI: 10.1093/bioinformatics/btae622.
Ford M, Hari A, Zhou Q, Numanagic I, Sahinalp S
bioRxiv. 2024; .
PMID: 39372800
PMC: 11451589.
DOI: 10.1101/2024.08.13.607835.
Tao S, You X, Norman P, Kichula K, Dong L, Chen N
HLA. 2024; 104(4):e15715.
PMID: 39364548
PMC: 11458138.
DOI: 10.1111/tan.15715.
Human NK cells and cancer.
Cantoni C, Falco M, Vitale M, Pietra G, Munari E, Pende D
Oncoimmunology. 2024; 13(1):2378520.
PMID: 39022338
PMC: 11253890.
DOI: 10.1080/2162402X.2024.2378520.
Prediction of KIR3DL1/Human Leukocyte Antigen binding.
Maiers M, Louzoun Y, Pymm P, Vivian J, Rossjohn J, Brooks A
bioRxiv. 2024; .
PMID: 38746109
PMC: 11092756.
DOI: 10.1101/2024.05.03.592082.
Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence.
Ferron E, David G, Willem C, Legrand N, Salameh P, Anquetil L
Front Immunol. 2024; 15:1389358.
PMID: 38736873
PMC: 11082329.
DOI: 10.3389/fimmu.2024.1389358.
High-resolution KIR and HLA genotyping in three Chinese ethnic minorities reveals distinct origins.
Tao S, Norman P, You X, Kichula K, Dong L, Chen N
HLA. 2024; 103(4):e15482.
PMID: 38625090
PMC: 11027949.
DOI: 10.1111/tan.15482.
Donor KIR2DL1 Allelic Polymorphism Influences Posthematopoietic Progenitor Cell Transplantation Outcomes in the T Cell Depleted and Reduced Intensity Conditioning Setting.
Wright P, van de Pasch L, Dignan F, Kichula K, Pollock N, Norman P
Transplant Cell Ther. 2024; 30(5):488.e1-488.e15.
PMID: 38369017
PMC: 11056303.
DOI: 10.1016/j.jtct.2024.02.014.
Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance.
Liu X, Zuo F, Song J, Tang L, Wang X, Liu X
Cell Discov. 2024; 10(1):16.
PMID: 38336855
PMC: 10858264.
DOI: 10.1038/s41421-024-00646-3.
Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure.
Laborda R, de Frias E, Subhi-Issa N, de Albornoz E, Melia E, Ordenes M
Sci Rep. 2024; 14(1):3354.
PMID: 38336826
PMC: 10858137.
DOI: 10.1038/s41598-024-53766-x.
Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab.
Lorig-Roach N, Harpell N, DuBois R
Sci Rep. 2024; 14(1):742.
PMID: 38185735
PMC: 10772121.
DOI: 10.1038/s41598-023-50262-6.
The repertoire of a West African chimpanzee population is characterized by limited gene, allele, and haplotype variation.
de Groot N, Heijmans C, van der Wiel M, Bruijnesteijn J, Bontrop R
Front Immunol. 2023; 14:1308316.
PMID: 38149259
PMC: 10750417.
DOI: 10.3389/fimmu.2023.1308316.
NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?.
Bjorgen J, Dick J, Cromarty R, Hart G, Rhein J
Front Immunol. 2023; 14:1267774.
PMID: 37928543
PMC: 10620977.
DOI: 10.3389/fimmu.2023.1267774.
and Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease.
Bernit E, Jean E, Marlot B, Laget L, Izard C, Dettori I
Int J Mol Sci. 2023; 24(17).
PMID: 37686397
PMC: 10487752.
DOI: 10.3390/ijms241713591.
Decision trees to evaluate the risk of developing multiple sclerosis.
Pasella M, Pisano F, Cannas B, Fanni A, Cocco E, Frau J
Front Neuroinform. 2023; 17:1248632.
PMID: 37649987
PMC: 10465164.
DOI: 10.3389/fninf.2023.1248632.
Correlation between human leukocyte antigen ligands and killer cell immunoglobulin-like receptors in aplastic anemia patients from Shaanxi Han.
Wang T, Qi J, Wang M, Xu H, Wu J, Shang L
Immunogenetics. 2023; 75(5):445-454.
PMID: 37592108
DOI: 10.1007/s00251-023-01316-6.
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells.
Palmer W, Leaton L, Campos Codo A, Crute B, Roest J, Zhu S
Sci Immunol. 2023; 8(84):eade5343.
PMID: 37390222
PMC: 10360443.
DOI: 10.1126/sciimmunol.ade5343.
The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells.
Kaulfuss M, Mietz J, Fabri A, Vom Berg J, Munz C, Chijioke O
Sci Rep. 2023; 13(1):10555.
PMID: 37386090
PMC: 10310841.
DOI: 10.1038/s41598-023-37779-6.